Disease | metabolic syndrome x |
Comorbidity | C0018799|heart disease |
Sentences | 21 |
PubMedID- 22548293 | metabolic syndrome is associated with coronary heart disease (chd) and new-onset diabetes after kidney transplant (nodat). |
PubMedID- 19969373 | We sought to determine whether psychological factors were associated with a greater prevalence of the metabolic syndrome in patients with coronary heart disease, and the extent to which such an association may be explained by socioeconomic status, health behaviors, and biological mediators. |
PubMedID- 21151616 | Unlike class i and iia hdacs, class iii hdacs play an important role in regulating oxidative stress in heart diseases with metabolic syndromes. |
PubMedID- 21186101 | metabolic syndrome was strongly associated with coronary heart disease (or = 4.03; 95% ci: 2.98, 5.45) and the risk seemed to be fully explained by metabolic syndrome components (or = 0.84, p = 0.54 after adjustment). |
PubMedID- 22780328 | Introduction: excessive abdominal obesity along with other risk factors results in the metabolic syndrome, which can lead to heart disease, type-2 diabetes, and death. |
PubMedID- 24793349 | Background and objectives: to evaluate the risk of coronary heart disease (chd) associated with metabolic syndrome (mets) and its individual components in a representative sample of diabetic and nondiabetic iranians. |
PubMedID- 23819342 | [comparative evaluation of the impact of four-week therapy with amlodipine and atenolol on quality of life and blood lipid composition in patients with coronary heart disease associated with metabolic syndrome]. |
PubMedID- 24174878 | After an additional follow-up period of 4.9 years, coronary artery calcium progression was able to predict coronary heart disease events in patients with metabolic syndrome and without type 2 diabetes, as well as in those with type 2 diabetes. |
PubMedID- 22355990 | Frequency of metabolic syndrome in patients with ischaemic heart disease. |
PubMedID- 26274823 | The relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function--an occupational cohort-based study. |
PubMedID- 23251156 | The increased risk of coronary heart disease in patients with the metabolic syndrome suggests that the insulin-resistant state is atherogenic without concomitant elevations in plasma glucose and glycosylated hemoglobin [26, 27]. |
PubMedID- 23479983 | [quality of life in patients with coronary heart disease associated with metabolic syndrome: results of factor analysis]. |
PubMedID- 21139493 | Procollagen iii n-terminal peptide predicts short-term prognosis and cardiac remodeling in coronary heart disease patients with metabolic syndrome. |
PubMedID- 22906266 | Associations between coronary heart disease and individual components of the metabolic syndrome according to glucose tolerance status. |
PubMedID- 23091851 | Aim: to define the pharmacogenetic features of the effect of metformin in coronary heart disease (chd) patients with metabolic syndrome (ms) or type 2 diabetes mellitus (t2dm), by taking into consideration ppar-gamma2 pro1 2ala polymorphism. |
PubMedID- 22131755 | [26] furthermore, insulin-resistant patients, with and without type 2 diabetes, are at an increased risk for developing metabolic syndrome, a major cause of heart disease, hypertension and dyslipidemia. |
PubMedID- 26401840 | Correction: the relationship of metabolic syndrome with stress, coronary heart disease and pulmonary function - an occupational cohort-based study. |
PubMedID- 21153653 | Obesity does not appear to be an independent predictor for the 10-year risk of coronary heart disease events in patients without metabolic syndrome treated with second-generation antipsychotics. |
PubMedID- 20940070 | Objective: we examined the risk of cardiovascular disease, stroke, ischaemic heart disease, and diabetes with the metabolic syndrome according to the new harmonised definition and its components using a national longitudinal data set from an asian population. |
PubMedID- 21636030 | We also discuss that a healthy lifestyle is essential for preventing and treating chronic kidney disease and coronary heart disease seen in patients with metabolic syndrome. |
PubMedID- 19935427 | The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease. |
Page: 1